Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-19

FDA Approved: CONJUPRI — Original Application (CSPC Ouyi Pharmaceutical Co. Ltd)

View source ↗

Summary

FDA approved CONJUPRI (levamlodipine) through an Original Application by CSPC Ouyi Pharmaceutical Co. Ltd for indications including hypertension and angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CONJUPRI (LEVAMLODIPINE)

Snippet

ORIG AP for CONJUPRI (LEVAMLODIPINE)